Document Detail

Improved oral anticoagulation after a dietary vitamin k-guided strategy: a randomized controlled trial.
MedLine Citation:
PMID:  19738137     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Dietary vitamin K is thought to be an important factor that interferes with anticoagulation stability, but the clinical applicability of this interaction has not been evaluated adequately in prospective studies. METHODS AND RESULTS: In a randomized controlled trial that enrolled outpatients with a recent international normalized ratio (INR) outside the therapeutic target, we compared 2 strategies to optimize long-term oral anticoagulation: (1) a conventional approach based on changes in anticoagulant prescription and (2) a dietary vitamin K-guided strategy based on simple modifications of the amount of vitamin K-rich foods ingested per week. The primary efficacy end point was the percentage of patients who achieved a prespecified INR target at 90 days after randomization. Study population (n=132) predominantly included men with mechanical heart prostheses (58%) or atrial fibrillation (35%). Over time, patients allocated to the vitamin K-guided strategy reached the prespecified INR more frequently so that after 90 days of follow-up, 74% were on target compared with 58% of patients managed conventionally (P=0.04). Patients allocated to the dietary vitamin K-guided strategy had the same magnitude and direction of INR variation as those observed with the conventional approach in the short term (15 days) for both underanticaogulated and overanticoagulated patients. Minor bleeding or use of parenteral vitamin K were also marginally less frequent in patients managed according to the dietary intervention (1 [1.5%] versus 7 [11%]; P=0.06). CONCLUSIONS: A vitamin K-guided management strategy to adjust long-term oral anticoagulation is feasible and safe and may result in an increased chance of reaching target levels of INR.
Michelli C de Assis; Eneida R Rabelo; Christiane W Avila; Carisi Anne Polanczyk; Luis E Rohde
Related Documents :
15764777 - A feasibility study of continuing dose-reduced warfarin for invasive procedures in pati...
23137667 - Predictive value of electrocorticography for postoperative epilepsy in patients with su...
11531177 - Secondary prevention of cerebral ischemia in patent foramen ovale: systematic review an...
1772297 - Antiphospholipid syndrome: five year follow up.
3852797 - A prospective study of postoperative fever in a general surgery department.
847417 - Cardiac valve replacement with the björk-shiley prosthesis in young patients.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2009-09-08
Journal Detail:
Title:  Circulation     Volume:  120     ISSN:  1524-4539     ISO Abbreviation:  Circulation     Publication Date:  2009 Sep 
Date Detail:
Created Date:  2009-09-22     Completed Date:  2009-10-08     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1115-22, 3 p following 1122     Citation Subset:  AIM; IM    
Cardiovascular Division of Hospital de Clínicas de Porto Alegre, Postgraduation Program in Cardiology and Cardiovascular Sciences, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
Data Bank Information
Bank Name/Acc. No.:
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Oral
Anticoagulants / administration & dosage*
Cross-Over Studies
International Normalized Ratio
Middle Aged
Vitamin K / administration & dosage*
Reg. No./Substance:
0/Anticoagulants; 12001-79-5/Vitamin K

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The first evaluation of a novel vitamin K antagonist, tecarfarin (ATI-5923), in patients with atrial...
Next Document:  Pathophysiological changes in calf muscle predict mobility loss at 2-year follow-up in men and women...